Dr Mahmood K. Razavi (St. Joseph Heart & Vascular Center, US) discusses the VIRTUS trial - Pivotal cohort 12-month primary safety and efficacy results of the Vici venous stent system.

Filmed by Radcliffe Vascular on site at LINC 2019.

Editorial Lead: Gary Swanston / David Ramsey 

Videographer: Tom Green

Questions:

1. What is the VIRTUS trial and what does it aim to address? (00:10)

2. What is the study design? (00:56)

3. What data are you presenting at LINC 2019? (01:42)

4. What conclusions can be made as a result of this data? (02:19)

5. What further research should be conducted with this device? (03:56)